Clinical Trial Update: A Study to Evaluate Indocyanine Green Lymphangiography to Improve Lymphadenectomy in Gastric Cancer Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating indocyanine green lymphangiography to improve lymphadenectomy in gastric cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Indocyanine green lymphangiography (indocyanine green)

Snippet

Sponsor: Mayo Clinic | Conditions: Gastric Cancer | Phase 4 | Status: WITHDRAWN